Insight Molecular Diagnostics Inc (IMDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 12-2013 | 12-2006 | |
| Cash Flows From Operating Activities | |||
| Net Income | -4,986 | -3,495 | N/A |
| Depreciation Amortization | 281 | 277 | N/A |
| Accounts payable and accrued liabilities | 291 | 48 | N/A |
| Other Working Capital | 3,223 | 2,182 | N/A |
| Other Operating Activity | 27 | 278 | 0 |
| Operating Cash Flow | $-1,164 | $-710 | $N/A |
| Cash Flows From Investing Activities | |||
| PPE Investments | -9 | -25 | N/A |
| Net Acquisitions | 1,329 | N/A | N/A |
| Investing Cash Flow | $1,320 | $-25 | $N/A |
| Cash Flows From Financing Activities | |||
| Financing Cash Flow | $N/A | $N/A | $N/A |
| Beginning Cash Position | 101 | 836 | N/A |
| End Cash Position | 257 | 101 | N/A |
| Net Cash Flow | $156 | $-735 | $N/A |
| Free Cash Flow | |||
| Operating Cash Flow | -1,164 | -710 | N/A |
| Capital Expenditure | -9 | -25 | N/A |
| Free Cash Flow | -1,173 | -735 | 0 |